In the EU-IGFD Registry, there is a high risk of bias for incomplete outcome data because a large proportion of enrolled patients discontinued the study early due to reasons other than completing the course of treatment or achieving final adult height, and baseline data were missing for many enrolled patients
For healthcare providers and patients alike, the message is clear: careful screening for pre-existing gastrointestinal conditions, a thorough discussion of potential risks, and prompt reporting of severe or persistent GI symptoms are essential components of safe and responsible medication use
and (3) their systemic roles beyond the liver can complicate safety profiles
Curcumin: a therapeutic potential in ageing-related disorders, Pharmanutrition
How long does each Ipamorelin injection remain active
It typically affects the legs and feet, but it can affect any part of your body, leading to pain, numbness, and sometimes loss of function